Skip to main content
. 2024 Nov 9;12:134. doi: 10.1186/s40364-024-00678-7

Fig. 1.

Fig. 1

Cumulative incidence curves for GG biopsy upgrade based on combined model at high-, intermediate-, and low-risk strata in the PASS and MDACC Cohorts. Risk tables, including censoring events, are provided beneath. Censoring was attributed to GG upgrading, prostate cancer treatment, voluntary withdrawal from AS, or loss to follow-up following biopsy